Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
Optimized CBT for Pts With High-risk Hematologic Malignancies Who Have Relapsed After First ASCT
M.D. Anderson Cancer Center
35 participants
Mar 3, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical research study is to learn if intermediate-intensity conditioning therapy followed by a cord blood transplant can help to control high-risk hematological malignancies in patients who need a second allogeneic stem cell transplantation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Given as standard of care treatment through IV infusion
Given as standard of care treatment through IV infusion
Given as standard of care treatment through IV infusion
Given as standard of care treatment through IV infusion
Given as standard of care treatment through IV infusion
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06807606